Impact of cultural and linguistic factors on symptom reporting by patients with cancer

Journal of the National Cancer Institute

Volumn 102, Issue 10, 2010, Pages 732-738

  Wang, Xin Shelley ^a   Cleeland, Charles S ^a   Mendoza, Tito R ^a   Yun, Young Ho ^c   Wang, Ying ^d   Okuyama, Toru ^e   Johnson, Valen E ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c National Cancer Center   (South Korea)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CLINICAL RESEARCH; CULTURAL FACTOR; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; HUMAN; LINGUISTICS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHOMETRY; SLEEP DISORDER; VOMITING;

ADULT; AGED; ANOREXIA; CHINA; CULTURAL CHARACTERISTICS; FATIGUE; FEMALE; HUMANS; JAPAN; KARNOFSKY PERFORMANCE STATUS; KOREA; LANGUAGE; MALE; MIDDLE AGED; NEOPLASMS; PAIN; QUESTIONNAIRES; RUSSIA; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; STRESS, PSYCHOLOGICAL; TRANSLATING; UNITED STATES;

EID: 77952923923     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq097     Document Type: Article

References (31)

1. Cleeland CS. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. 2007;37:16-21.
2. US Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry (draft). Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInf ormation/Guidances/UCM071975.pdf. Accessed March 15, 2010.
3. Benedetti C, Brock C, Cleeland C, et al. NCCN practice guidelines for cancer pain. Oncology (Huntington). 2000;14(11A):135-150.
4. Berger AM, Abernethy AP, Atkinson A, et al. NCCN Clinical Practice Guidelines in Oncology: cancer-related fatigue. 2008. http://www.nccn.org/ professionals/physician-gls/PDF/fatigue.pdf. Accessed December 10, 2008.
5. Swarm R, Anghelescu DL, Benedetti C, et al. Adult cancer pain. J Natl Compr Canc Netw. 2007;5(8):726-751.
6. Eaton LH, Tipton JM. Putting Evidence Into Practice: Improving Oncology Patient Outcomes. 1st ed. Pittsburgh, PA: Oncology Nursing Society; 2009.
7. Bowden A, Fox-Rushby JA. A systematic and critical review of the process of translation and adaptation of generic health-related quality of life measures in Africa, Asia, Eastern Europe, the Middle East, South America. Soc Sci Med. 2003;57(7):1289-1306.
8. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89(7):1634-1646.
9. Kirkova J, Davis MP, Walsh D, et al. Cancer symptom assessment instruments: a systematic review. J Clin Oncol. 2006;24(9):1459-1473.
10. Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS. Chinese version of the M.D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004;101(8):1890-1901.
11. Okuyama T, Wang XS, Akechi T, et al. Japanese version of the M.D. Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003;26(6):1093-1104. (Pubitemid 37488017)
12. Ivanova MO, Ionova TI, Kalyadina SA, et al. Cancer-related symptom assessment in Russia: validation and utility of the Russian M.D. Anderson Symptom Inventory. J Pain Symptom Manage. 2005;30(5):443-453.
13. Yun YH, Mendoza TR, Kang IO, et al. Validation study of the Korean version of the M.D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006;31(4):345-352.
14. Wang XS, Mendoza TR, Gao SZ, Cleeland CS. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain. 1996;67(2-3):407-416.
15. Cronbach LJ. Coeffcient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297-334.
16. Johnson VE, Albert J. Ordinal Data Modeling. New York, NY: Springer-Verlag; 1999.
17. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-655.
18. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277-284.
19. de Haes JC, Olschewski M. Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancer. Ann Oncol. 1998;9(7):745-750.
20. Wagner AK, Gandek B, Aaronson NK, et al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):925-932.
21. Allik J. Personality dimensions across cultures. J Pers Disord. 2005; 19(3):212-232.
22. Kim M, Han HR, Phillips L. Metric equivalence assessment in cross-cultural research: using an example of the Center for Epidemiological Studies-Depression Scale. J Nurs Meas. 2003;11(1):5-18.
23. Cleeland CS, Nakamura Y, Mendoza TR, Edwards KR, Douglas J, Serlin RC. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996;67(2-3):267-273.
24. Scott NW, Fayers PM, Bottomley A, et al. Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses. Qual Life Res. 2006;15(6):1103-1115.
25. Hahn EA, Holzner B, Kemmler G, Sperner-Unterweger B, Hudgens SA, Cella D. Cross-cultural evaluation of health status using item response theory: FACT-B comparisons between Austrian and U.S. patients with breast cancer. Eval Health Prof. 2005;28(2):233-259.
26. Anderson RT, Aaronson NK, Bullinger M, McBee WL. A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research. Pharmacoeconomics. 1996;10(4):336-355.
27. Acquadro C, Conway K, Hareendran A, Aaronson N. Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Health. 2008;11(3):509-521.
28. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46(12):1417-1432.
29. World Health Organization. Cancer pain relief: with a guide to opioid availability. 1994. http://whqlibdoc.who.int/publications/9241544821.pdf. Accessed July 14, 2009.
30. Cleeland CS, Gonin R, Hatfeld AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330(9):592-596.
31. Laugsand EA, Kaasa S, de CF, Hanks G, Klepstad P. Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network. J Opioid Manag. 2009;5(1):11-21.